 |
|
Severe Hypersensitivity Syndrome Due to Sulfasalazine Associated With Reactivation of Human Herpesvirus 6
Mikiko Tohyama, MD;
Yoko Yahata, MD;
Masaki Yasukawa, MD, PhD;
Reiko Inagi, PhD;
Yoshio Urano, MD, PhD;
Koichi Yamanishi, MD, PhD;
Koji Hashimoto, MD, PhD
Arch Dermatol. 1998;134:1113-1117.
Background A severe adverse reaction to sulfasalazine therapy has been associated with hypersensitivity syndrome, the clinical features of which are similar to infectious mononucleosis. No serologic evidence of viral infections has been reported with this syndrome; however, human herpesvirus 6 infection has not been specifically investigated, which could cause an infectious mononucleosislike syndrome.
Observations We report 2 cases of hypersensitivity syndrome induced by the use of sulfasalazine. The clinical features of the syndrome appeared 18 and 32 days after administration of sulfasalazine. Clinical signs included a maculopapular rash progressing to exfoliative erythroderma, fever, and lymphadenopathy. Leukocytosis, atypical lymphocytes, liver dysfunction, and renal disturbance were also observed. In 1 patient, human herpesvirus 6 variant B was isolated from peripheral blood mononuclear cells, and in both patients anti–human herpesvirus 6 IgG titers increased considerably.
Conclusions Two cases of hypersensitivity syndrome due to sulfasalazine use were associated with the reactivation of human herpesvirus 6, which may be a required cause of hypersensitivity syndrome.
From the Department of Dermatology (Drs Tohyama, Yahata, and Hashimoto) and the First Department of Internal Medicine (Dr Yasukawa), Ehime University School of Medicine, Ehime, the Department of Microbiology, Osaka University Medical School, Osaka (Drs Inagi and Yamanishi), and the Department of Dermatology, Tokushima University School of Medicine, Tokushima (Dr Urano), Japan.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
Human Herpesviruses 6 and 7: New Roles Yet to Be Discovered?
Laurence Le Cleach, Anne Marie Fillet, Henri Agut, and Olivier Chosidow
Arch Dermatol. 1998;134(9):1155-1157.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms: A Cause of Unpredictable Multiorgan Failure
Eshki et al.
Arch Dermatol 2009;145:67-72.
ABSTRACT
| FULL TEXT
Toxic Epidermal Necrolysis Due to Zonisamide Associated With Reactivation of Human Herpesvirus 6
Teraki et al.
Arch Dermatol 2008;144:232-235.
ABSTRACT
| FULL TEXT
Codeine Phosphate-Induced Hypersensitivity Syndrome
Enomoto et al.
The Annals of Pharmacotherapy 2004;38:799-802.
ABSTRACT
| FULL TEXT
Association Between Anticonvulsant Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation and Hypogammaglobulinemia
Kano et al.
Arch Dermatol 2004;140:183-188.
ABSTRACT
| FULL TEXT
Is a Drug Alone Sufficient to Cause the Drug Hypersensitivity Syndrome?
Wong and Shear
Arch Dermatol 2004;140:226-230.
FULL TEXT
Phenotypic and Functional Alterations of Dendritic Cells Induced by Human Herpesvirus 6 Infection
Kakimoto et al.
J. Virol. 2002;76:10338-10345.
ABSTRACT
| FULL TEXT
Drug Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation
Tohyama et al.
Arch Dermatol 2002;138:268-269.
FULL TEXT
Drug-Induced Hypersensitivity Syndrome in Pediatric Patients
Carroll et al.
Pediatrics 2001;108:485-492.
ABSTRACT
| FULL TEXT
Association of Human Herpesvirus 6 Infection With Drug Reaction With Eosinophilia and Systemic Symptoms
Descamps et al.
Arch Dermatol 2001;137:301-304.
ABSTRACT
| FULL TEXT
Transcriptional Down-Regulation of CXC Chemokine Receptor 4 Induced by Impaired Association of Transcription Regulator YY1 with c-Myc in Human Herpesvirus 6-Infected Cells
Hasegawa et al.
J. Immunol. 2001;166:1125-1131.
ABSTRACT
| FULL TEXT
Human Herpesviruses 6 and 7: New Roles Yet to Be Discovered?
Le Cleach et al.
Arch Dermatol 1998;134:1155-1157.
FULL TEXT
|
